Medbroadcast  Powered by MediResource
 Search

Go
 Browse alphabetically
ABCDEFGHIJKLMN
OPQRSTUVWXYZ
HEALTH TOPICS
Family & Child Health
Men's Health
Women's Health
Seniors' Health
Addiction
Allergy
Ankylosing Spondylitis
Arthritis (Rheumatoid)
Asthma
Atrial Fibrillation
Baby Health
Back Health
Bedwetting
Bladder (Overactive)
Brain Health
Cancer
Childhood Vaccinations
Cholesterol
Crohn's & Colitis
Cold and Flu
COPD NEW!
Cosmetic Procedures
Depression NEW!
Diabetes
Digestive Health
Ear Health
Eating Disorders
Eye Health
Flu (Seasonal)
Fertility
Fitness
Healthy Skin
Heart
High Blood Pressure
HPV
Hyperhidrosis
Incontinence
Infection
Kidney Health
Lung Health
Medications and your Health
Menopause
Mental Health
Multiple Sclerosis NEW!
Natural and Complementary Therapy
Nutrition
Obesity
Oral Care
Osteoarthritis of the Knee NEW!
Pain
Pregnancy
Psoriasis
Psoriatic Arthritis (PsA)
Seasonal Health
Sexual Health
Sleep Health
Stroke Risk Reduction
Smoking
Weight Management
Workplace Health
Yeast Infection
All health channels

STAY CONNECTED
RESOURCES
Ask an Expert
Clinical Trials
Find a Specialist
Health features
News
Tools


Condition Info Drug Info Tests and Procedures Natural Products Ask an Expert Support Groups Clinical Trials
Home Bookmark Page Send to a Friend Sante Chez Nous Subscribe
Drug Info > F > Fraxiparine
Please enter the drug name or
DIN (Drug Identification Number)


GoGO

Search by first letter

ABCDEFGHIJKLMNOPQRSTUVWXYZ

Brand Name

Fraxiparine

Common Name
nadroparin


In this drug factsheet:



DIN (Drug Identification Number)

02236913 FRAXIPARINE 9500 IU/ML SOLUTION
02240114 FRAXIPARINE FORTE 19 000 IU/ML SOLUTION

How does this medication work? What will it do for me?

Nadroparin belongs to the class of medications known as anticoagulants or antithrombotic agents. These medications reduce the clotting ability of the blood and can reduce the risk of harmful blood clots forming in blood vessels.

Nadroparin is used to prevent and treat deep vein thrombosis (DVT). This condition leads to the formation of blood clots in the blood vessels in the leg. These blood clots can sometimes travel to the lungs and block blood vessels there, resulting in a serious condition known as pulmonary embolism.

Nadroparin is used to prevent DVT and pulmonary embolism in people who are undergoing general surgery or orthopaedic surgery (e.g., hip or knee replacement). It is also used to prevent clotting in people undergoing hemodialysis. Nadroparin is also used to treat unstable angina and heart attack survivors.

Your doctor may have suggested this medication for conditions other than those listed in these drug information articles. As well, some forms of this medication may not be used for all of the conditions discussed here. If you have not discussed this with your doctor or are not sure why you are being given this medication, speak to your doctor. Do not stop using this medication without consulting your doctor.

Do not give this medication to anyone else, even if they have the same symptoms as you do. It can be harmful for people to use this medication if their doctor has not prescribed it.

How should I use this medication?

The recommended dose depends on the individual and the condition being treated. Nadroparin is injected under the skin (subcutaneously). Your doctor will recommend the dose that is most likely to prevent blood clots yet not cause you to bleed easily. Your doctor or health care professional will show you how to inject the medication yourself. If you have any questions about how to use the medication, contact your doctor.

Steps to use the medication:

  1. Before injecting nadroparin, wash your hands and the area of skin you will inject. Only use the injection if the solution appears clear and particle-free.
  2. Lie down and gently pinch a fold of skin (usually in the lower abdomen) between your finger and thumb. Choose alternate places on the lower abdomen for each injection (e.g., right side one day, left side the next day).
  3. Push the entire needle vertically into the skin and then press down on the syringe plunger to inject the medication. Make sure you are holding the skin the entire time you are injecting the needle and pressing down on the syringe plunger.
  4. After giving the injection, remove the needle from the skin. Use the safety shield to prevent the needle from injuring others.
  5. Use an alcohol swab to apply light pressure to the injection area for several seconds. Do not rub the site afterwards.
  6. Dispose of the syringe and needle safely (using a sharps container). Each syringe is for a single use only.

Many things can affect the dose of a medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are using the medication without consulting your doctor.

It is important to use this medication exactly as prescribed by your doctor. If you miss a dose, contact your doctor or pharmacist. Do not inject a double dose to make up for a missed one.

Store this medication at room temperature and keep it out of the reach of children. Do not refrigerate or freeze the medication.

Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.





What form(s) does this medication come in?

Fraxiparine® Prefilled Syringes
Each mL of aqueous solution contains nadroparin calcium 9,500 anti-Xa IU. Single dose, disposable prefilled glass syringes of 0.3 mL (ungraduated green syringes), 2,850 anti-Xa IU; 0.4 mL (ungraduated orange syringes), 3,800 anti-Xa IU; 0.6 mL (graduated brown syringes), 5,700 anti-Xa IU; 0.8 mL (graduated green [teal] syringes), 7,600 anti-Xa IU; and 1 mL (graduated violet syringes), 9,500 anti-Xa IU.

Fraxiparine Forte® Prefilled Syringes
Each mL of aqueous solution contains nadroparin calcium 19,000 anti-Xa IU. Single dose, disposable prefilled glass syringes of 0.6 mL (graduated process blue syringes, 11,400 anti-Xa IU; 0.8 mL (graduated magenta syringes), 15,200 anti-Xa IU; and 1 mL (graduated reflex blue syringes), 19,000 anti-Xa IU.

Who should NOT take this medication?

Do not use this mediction if you:

  • are allergic to nadroparin or to any of the ingredients of the medication
  • are allergic to other low-molecular-weight heparins or heparin
  • currently have or have previously had heparin-induced thrombocytopenia (decrease in the number of platelets), or test positive in a platelet-aggregation test while using nadroparin
  • have a history of bleeding in the brain
  • have a severe blood clotting disorder
  • have active bleeding, bleeding tendencies, or other conditions that could have an increased risk of bleeding
  • have acute infective endocarditis (bacterial infection of the heart)
  • have bleeding due to ulcers (e.g., active stomach or duodenal ulcers)
  • have eye problems due to diabetes or bleeding
  • have injuries to and have had operations on the brain, spinal cord, eyes, or ears
  • have severe kidney problems (unless you are using nadroparin to prevent clot formation during dialysis)
  • have uncontrolled high blood pressure
  • received spinal anaesthesia and need many doses of nadroparin


 

Advertisement


Did you find what you were looking for on our website? Please let us know.


 Search for information related to
GO
ABCDEFGHIJKLMNOPQRSTUVWXYZ
 

Hot Topics - Bedwetting, Depression, Flu (Seasonal), Healthy Skin, Incontinence, Multiple Sclerosis, Psoriasis, Stroke Risk Reduction

Condition and disease information is written and reviewed by the MedBroadcast Clinical Team.


The contents of this site are for informational purposes only and are meant to be discussed with your physician or other qualified health care professional before being acted on. Never disregard any advice given to you by your doctor or other qualified health care professional. Always seek the advice of a physician or other licensed health care professional regarding any questions you have about your medical condition(s) and treatment(s). This site is not a substitute for medical advice.
© 1996 - 2014 MediResource Inc. - MediResource reaches millions of Canadians each year.